In vitro Activity and Function of B7-H4-Ig Fusion Protein

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

In vitro Activity and Function of B7-H4-Ig Fusion Protein. / Rasmussen, Susanne B; Kosicki, Michael; Svendsen, Signe Goul; Claesson, Mogens Helweg; Kristensen, Nanna Ny.

In: Open Journal of Immunology, Vol. 3, No. 1, 2013, p. 24-32.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rasmussen, SB, Kosicki, M, Svendsen, SG, Claesson, MH & Kristensen, NN 2013, 'In vitro Activity and Function of B7-H4-Ig Fusion Protein', Open Journal of Immunology, vol. 3, no. 1, pp. 24-32. https://doi.org/10.4236/oji.2013.31004

APA

Rasmussen, S. B., Kosicki, M., Svendsen, S. G., Claesson, M. H., & Kristensen, N. N. (2013). In vitro Activity and Function of B7-H4-Ig Fusion Protein. Open Journal of Immunology, 3(1), 24-32. https://doi.org/10.4236/oji.2013.31004

Vancouver

Rasmussen SB, Kosicki M, Svendsen SG, Claesson MH, Kristensen NN. In vitro Activity and Function of B7-H4-Ig Fusion Protein. Open Journal of Immunology. 2013;3(1):24-32. https://doi.org/10.4236/oji.2013.31004

Author

Rasmussen, Susanne B ; Kosicki, Michael ; Svendsen, Signe Goul ; Claesson, Mogens Helweg ; Kristensen, Nanna Ny. / In vitro Activity and Function of B7-H4-Ig Fusion Protein. In: Open Journal of Immunology. 2013 ; Vol. 3, No. 1. pp. 24-32.

Bibtex

@article{89dc34f7bbc546b186e3df7b3eacd67e,
title = "In vitro Activity and Function of B7-H4-Ig Fusion Protein",
abstract = "B7-H4 has been shown to inhibit T cell proliferation, cytokine production and cell cycle in vitro. B7-H4 deficient mice develop exacerbated disease in the mouse models of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D) and Experimental Autoimmune Encephalomyelitis (EAE). On the other hand, B7-H4-Ig fusion protein has been documented to assuage the symptoms in mouse models of RA, T1D, and multiple sclerosis in vivo. In the present study, B7-H4-Ig bound to the majority of human peripheral blood monocytes and NK cells, but not to either normal or activated T cells. B7-H4-Ig fusion protein was assayed for its effects in allogeneic mixed lymphocyte culture (MLC) systems. Soluble B7- H4-Ig had no significant effect in the MLC, but with a tendency to promote allogeneic response. Immobilized, but not soluble B7-H4-Ig inhibited plastic bound anti-CD3 mediated activation of T cells. This inhibition however was largely due to B7-H4-Ig mediated displacement of anti-CD3 antibody from the plastic plate. Finally, B7-H4-Ig had no effect on the cytotoxicity mediated by NK and LAK cells in PBMC. Our findings thus caution against the interpretation of suppressive effect observed solely in plate-bound anti-CD3 mediated T cell co-stimulation in vitro.",
keywords = "Faculty of Health and Medical Sciences, CD28 Family, B7-H4, Fusion Protein, MLC",
author = "Rasmussen, {Susanne B} and Michael Kosicki and Svendsen, {Signe Goul} and Claesson, {Mogens Helweg} and Kristensen, {Nanna Ny}",
year = "2013",
doi = "10.4236/oji.2013.31004",
language = "English",
volume = "3",
pages = "24--32",
journal = "Open Journal of Immunology",
issn = "2162-450X",
publisher = "Scientific Research Publishing, Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - In vitro Activity and Function of B7-H4-Ig Fusion Protein

AU - Rasmussen, Susanne B

AU - Kosicki, Michael

AU - Svendsen, Signe Goul

AU - Claesson, Mogens Helweg

AU - Kristensen, Nanna Ny

PY - 2013

Y1 - 2013

N2 - B7-H4 has been shown to inhibit T cell proliferation, cytokine production and cell cycle in vitro. B7-H4 deficient mice develop exacerbated disease in the mouse models of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D) and Experimental Autoimmune Encephalomyelitis (EAE). On the other hand, B7-H4-Ig fusion protein has been documented to assuage the symptoms in mouse models of RA, T1D, and multiple sclerosis in vivo. In the present study, B7-H4-Ig bound to the majority of human peripheral blood monocytes and NK cells, but not to either normal or activated T cells. B7-H4-Ig fusion protein was assayed for its effects in allogeneic mixed lymphocyte culture (MLC) systems. Soluble B7- H4-Ig had no significant effect in the MLC, but with a tendency to promote allogeneic response. Immobilized, but not soluble B7-H4-Ig inhibited plastic bound anti-CD3 mediated activation of T cells. This inhibition however was largely due to B7-H4-Ig mediated displacement of anti-CD3 antibody from the plastic plate. Finally, B7-H4-Ig had no effect on the cytotoxicity mediated by NK and LAK cells in PBMC. Our findings thus caution against the interpretation of suppressive effect observed solely in plate-bound anti-CD3 mediated T cell co-stimulation in vitro.

AB - B7-H4 has been shown to inhibit T cell proliferation, cytokine production and cell cycle in vitro. B7-H4 deficient mice develop exacerbated disease in the mouse models of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D) and Experimental Autoimmune Encephalomyelitis (EAE). On the other hand, B7-H4-Ig fusion protein has been documented to assuage the symptoms in mouse models of RA, T1D, and multiple sclerosis in vivo. In the present study, B7-H4-Ig bound to the majority of human peripheral blood monocytes and NK cells, but not to either normal or activated T cells. B7-H4-Ig fusion protein was assayed for its effects in allogeneic mixed lymphocyte culture (MLC) systems. Soluble B7- H4-Ig had no significant effect in the MLC, but with a tendency to promote allogeneic response. Immobilized, but not soluble B7-H4-Ig inhibited plastic bound anti-CD3 mediated activation of T cells. This inhibition however was largely due to B7-H4-Ig mediated displacement of anti-CD3 antibody from the plastic plate. Finally, B7-H4-Ig had no effect on the cytotoxicity mediated by NK and LAK cells in PBMC. Our findings thus caution against the interpretation of suppressive effect observed solely in plate-bound anti-CD3 mediated T cell co-stimulation in vitro.

KW - Faculty of Health and Medical Sciences

KW - CD28 Family

KW - B7-H4

KW - Fusion Protein

KW - MLC

U2 - 10.4236/oji.2013.31004

DO - 10.4236/oji.2013.31004

M3 - Journal article

VL - 3

SP - 24

EP - 32

JO - Open Journal of Immunology

JF - Open Journal of Immunology

SN - 2162-450X

IS - 1

ER -

ID: 91448940